Identification and characterization of a loss-of-function human MPYS variant

L Jin1, L-G Xu, I V Yang

  • 1Integrated Department of Immunology, University of Colorado Denver School of Medicine and National Jewish Health, Denver, CO 80206-2762, USA.

Genes and Immunity
|January 21, 2011
PubMed

Insights

A newly identified MPYS gene variant, the HAQ haplotype, significantly impairs interferon-beta production, potentially increasing susceptibility to infections and reducing vaccine efficacy in approximately 3% of Americans.

Area of Science:

  • Immunology
  • Genetics

Background:

  • MPYS (also known as STING and MITA) is crucial for innate immunity, stimulating interferon-beta (IFNβ) production.
  • MPYS plays a role in host defense against pathogens and enhances DNA vaccine adjuvant activity.

Purpose of the Study:

  • To identify and characterize a novel human MPYS haplotype.
  • To investigate the functional consequences of this haplotype on IFNβ production and host defense.

Main Methods:

  • Identification of a distinct human MPYS haplotype (R71H-G230A-R293Q, termed HAQ).
  • Genotyping in two cohorts (1,074 individuals) to estimate HAQ haplotype frequency.
  • Functional assays using fibroblasts and macrophages to assess IFNβ production and response to Listeria monocytogenes.

Main Results:

  • Approximately 3% of Americans are homozygous for the HAQ MPYS haplotype.
  • HAQ MPYS demonstrates a >90% loss in IFNβ stimulatory capacity.
  • Cells expressing HAQ are impaired in IFNβ production following Listeria monocytogenes infection.
  • The R71H and R293Q SNPs are primarily responsible for the reduced IFNβ activity.

Conclusions:

  • The HAQ MPYS haplotype significantly compromises the innate immune response by impairing IFNβ production.
  • Individuals homozygous for HAQ may face increased susceptibility to viral infections.
  • The HAQ haplotype might lead to a diminished response to DNA vaccines.